Cited by 780Parkinson's Disease Mechanisms and TreatmentsCoffee research and impactsDementia and Cognitive Impairment Research

The DOI matches its Crossref record; 35 of the 35 references it cites were found in a registry or an index.

Association of Coffee and Caffeine Intake With the Risk of Parkinson Disease

Ross, G. Webster·2000·JAMA

DOI 10.1001/jama.283.20.2674

Open this paper in CoChat — free account

Abstract

CONTEXT: The projected expansion in the next several decades of the elderly population at highest risk for Parkinson disease (PD) makes identification of factors that promote or prevent the disease an important goal. OBJECTIVE: To explore the association of coffee and dietary caffeine intake with risk of PD. DESIGN, SETTING, AND PARTICIPANTS: Data were analyzed from 30 years of follow-up of 8004 Japanese-American men (aged 45-68 years) enrolled in the prospective longitudinal Honolulu Heart Program between 1965 and 1968. MAIN OUTCOME MEASURE: Incident PD, by amount of coffee intake (measured at study enrollment and 6-year follow-up) and by total dietary caffeine intake (measured at enrollment). RESULTS: During follow-up, 102 men were identified as having PD. Age-adjusted incidence of PD declined consistently with increased amounts of coffee intake, from 10.4 per 10,000 person-years in men who drank no coffee to 1.9 per 10,000 person-years in men who drank at least 28 oz/d (P<.001 for trend). Similar relationships were observed with total caffeine intake (P<.001 for trend) and caffeine from non-coffee sources (P=.03 for trend). Consumption of increasing amounts of coffee was also associated with lower risk of PD in men who were never, past, and current smokers at baseline (P=.049, P=.22, and P=.02, respectively, for trend). Other nutrients in coffee, including niacin, were unrelated to PD incidence. The relationship between caffeine and PD was unaltered by intake of milk and sugar. CONCLUSIONS: Our findings indicate that higher coffee and caffeine intake is associated with a significantly lower incidence of PD. This effect appears to be independent of smoking. The data suggest that the mechanism is related to caffeine intake and not to other nutrients contained in coffee. JAMA. 2000;283:2674-2679.

Integrity signals

Registry

Crossref · 10.1001/jama.283.20.2674

Cites

35 of 35 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Regression Models and Life-Tables
Cox, D. R. (1972) · Journal of the Royal Statistical Society Series B: Statistical Methodology · doi:10.1111/j.2517-6161.1972.tb00899.x · Cited by 39,793
Regression Models and Life-Tables
Cox, D. R. (1992) · Springer Series in Statistics · doi:10.1007/978-1-4612-4380-9_37 · Cited by 26,297
Parkinson's Disease
Lang, A. E., & Lozano, A. M. (1998) · New England Journal of Medicine · doi:10.1056/nejm199810083391506 · Cited by 2,072
Caffeine and the central nervous system: mechanisms of action, biochemical, metabolic and psychostimulant effects
Nehlig, A., Daval, J., & Debry, G. (1992) · Brain Research Reviews · doi:10.1016/0165-0173(92)90012-b · Cited by 1,463
Parkinson Disease in Twins
Tanner, C. M., Ottman, R., Goldman, S. M., Ellenberg, J., Chan, P., Mayeux, R. P., & Langston, J. W. (1999) · JAMA · doi:10.1001/jama.281.4.341 · Cited by 876
Epidemiology of parkinson’s disease
Tanner, C. M., & Goldman, S. M. (1996) · Neurologic Clinics · doi:10.1016/s0733-8619(05)70259-0 · Cited by 640
Coffee, Alcohol and Risk of Coronary Heart Disease among Japanese Men Living in Hawaii
Yano, K., Rhoads, G. G., & Kagan, A. (1977) · New England Journal of Medicine · doi:10.1056/nejm197708252970801 · Cited by 524
Prevalence of Dementia in Older Japanese-American Men in Hawaii: The Honolulu-Asia Aging Study
White, L. (1996) · JAMA · doi:10.1001/jama.1996.03540120033030 · Cited by 437
TEN-YEAR INCIDENCE OF CORONARY HEART DISEASE IN THE HONOLULU HEART PROGRAM
Yano, K., REED, D. M., & McGee, D. (1984) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a113787 · Cited by 370
Worldwide Occurrence of Parkinson's Disease: An Updated Review
Zhang, Z., & Román, G. C. (1993) · Neuroepidemiology · doi:10.1159/000110318 · Cited by 332

Show all 35 references

Sorted by citations

Items 301–400 of 780

Understanding Caffeine’s Role in Attenuating the Toxicity of α-Synuclein Aggregates: Implications for Risk of Parkinson’s Disease
Kardani, J., & Roy, I. (2015) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.5b00158 · Cited by 43
Association of coffee consumption and non-motor symptoms in drug-naïve, early-stage Parkinson's disease
Cho, B., Choi, S., Kim, J., & Kim, B. C. (2018) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2018.02.016 · Cited by 43
Relationship between caffeine intake and Parkinson disease.
Ross, G., Abbott, R., Petrovitch, H., White, L., & Tanner, C. M. (2000) · PubMed · Cited by 42
Self-citation
Identification of Phytochemical Compounds in Coffea arabica Whole Coffee Cherries and Their Extracts by LC-MS/MS
Nemzer, B. V., Abshiru, N. A., & Al-Taher, F. (2021) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.0c05937 · Cited by 41
Parkinson's disease research in a prospective cohort in China
Chen, H., Ding, D., Wang, J., Zhao, Q., Meng, H., Li, H., Gao, Y.-T., Shu, X., Tanner, C. M., Hong, Z., et al. (2015) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2015.08.020 · Cited by 41
Ageing‐related decline in adenosine A1 receptor binding in the rat brain: An autoradiographic study
Meerlo, P., Román, V., Farkas, E., Keijser, J. N., Nyakas, C. J., & Luiten, P. G. M. (2004) · Journal of Neuroscience Research · doi:10.1002/jnr.20314 · Cited by 40
Impact of infection on risk of Parkinson’s disease: a quantitative assessment of case-control and cohort studies
Meng, L., Shen, L., & Ji, H. (2019) · Journal of NeuroVirology · doi:10.1007/s13365-018-0707-4 · Cited by 41
Coffee, caffeine‐related genes, and Parkinson's disease: A case–control study
Facheris, M., Schneider, N. K., Lesnick, T. G., de Andrade, M., Cunningham, J. M., Rocca, W. A., & Maraganore, D. M. (2008) · Movement Disorders · doi:10.1002/mds.22247 · Cited by 41
Adenosine A2A receptor antagonists: Potential therapeutic and neuroprotective effects in parkinson’s disease
Morelli, M., & Wardas, J. (2001) · Neurotoxicity Research · doi:10.1007/bf03033210 · Cited by 41
Formation of stacking complexes between caffeine (1,2,3-trimethylxanthine) and 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine may attenuate biological effects of this neurotoxin
Ulanowska, K., Piosik, J., Gwizdek‐Wiśniewska, A., & ̧grzyn, G. W. (2005) · Bioorganic Chemistry · doi:10.1016/j.bioorg.2005.07.004 · Cited by 40
Caffeine and Stress: Implications for Risk, Assessment, and Management of Hypertension
Hartley, T. R., Lovallo, W. R., Whitsett, T. L., Sung, B. H., & Wilson, M. F. (2001) · Journal of Clinical Hypertension · doi:10.1111/j.1524-6175.2001.00478.x · Cited by 42
Dopaminergic imaging in degenerative parkinsonisms, an established clinical diagnostic tool
Nicastro, N., Nencha, U., Burkhard, P. R., & Garibotto, V. (2021) · Journal of Neurochemistry · doi:10.1111/jnc.15561 · Cited by 41
Newly Approved and Investigational Drugs for Motor Symptom Control in Parkinson's Disease
Luca, D. G. D., Reyes, N. G. D., & Fox, S. H. (2022) · Drugs · doi:10.1007/s40265-022-01747-7 · Cited by 39
Niacin metabolism and Parkinson’s disease
Fukushima, T. (2005) · Environmental Health and Preventive Medicine · doi:10.1265/ehpm.10.3 · Cited by 39
Medical Management of Parkinsons Disease: Focus on Neuroprotection
Rı́os, C., Boll, M., & Alcaraz-Zubeldia, M. (2011) · Current Neuropharmacology · doi:10.2174/157015911795596577 · Cited by 39
Caffeine Prevents Blood Retinal Barrier Damage in a Model, In Vitro, of Diabetic Macular Edema
Maugeri, G., D’Amico, A. G., Rasà, D. M., Cognata, V. L., Saccone, S., Federico, C., Cavallaro, S., & D’Agata, V. (2017) · Journal of Cellular Biochemistry · doi:10.1002/jcb.25899 · Cited by 40
Preventive treatments to slow substantia nigra damage and Parkinson’s disease progression: A critical perspective review
Bjørklund, G., Dadar, M., Anderson, G., Chirumbolo, S., & Maes, M. H. J. (2020) · Pharmacological Research · doi:10.1016/j.phrs.2020.105065 · Cited by 39
Do caffeine and more selective adenosine A2A receptor antagonists protect against dopaminergic neurodegeneration in Parkinson's disease?
Chen, J.-F., & Schwarzschild, M. A. (2020) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2020.10.024 · Cited by 39
Discovery of novel dual adenosine A1/A2A receptor antagonists using deep learning, pharmacophore modeling and molecular docking
Wang, M., Hou, S., Wei, Y., Li, D., & Lin, J. (2021) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1008821 · Cited by 38
Caffeine and Progression of Parkinson Disease
Simon, D. K., Swearingen, C. J., Hauser, R. A., Trugman, J. M., Aminoff, M. J., Singer, C., Truong, D. D., & Tilley, B. C. (2008) · Clinical Neuropharmacology · doi:10.1097/wnf.0b013e31815a3f03 · Cited by 38
Caffeine challenge test and panic disorder: a systematic literature review
Vilarim, M. M., Araújo, D. M. R., & Nardi, A. E. (2011) · Expert Review of Neurotherapeutics · doi:10.1586/ern.11.83 · Cited by 39
Niacin improved rigidity and bradykinesia in a Parkinson's disease patient but also caused unacceptable nightmares and skin rash–a case report
Alisky, J. M. (2005) · Nutritional Neuroscience · doi:10.1080/10284150500484638 · Cited by 38
Late-life hemoglobin and the incidence of Parkinson's disease
Abbott, R. D., Ross, G. W., Tanner, C. M., Andersen, J. K., Masaki, K., Rodríguez, B. L., White, L. R., & Petrovitch, H. (2010) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2010.06.023 · Cited by 40
Self-citation
Neuroprotective Potential of Adenosine A2Aand Cannabinoid CB1Receptor Antagonists in an Animal Model of Parkinson Disease
Cerri, S., Levandis, G., Ambrosi, G., Montepeloso, E., Antoninetti, G., Franco, R., Lanciego, J. L., Baqi, Y., Müller, C. E., Pinna, A., et al. (2014) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/nen.0000000000000064 · Cited by 38
Voluptuary habits and clinical subtypes of Parkinson's disease: The FRAGAMP case–control study
Nicoletti, A. S. Q., Pugliese, P., Nicoletti, G., Arabia, G., Annesi, G., Mari, M. D., Lamberti, P., Grasso, L., Marconi, R., Epifanio, A., et al. (2010) · Movement Disorders · doi:10.1002/mds.23297 · Cited by 38
The Effect of Adenosine A2A Receptor Antagonists on Hydroxyl Radical, Dopamine, and Glutamate in the Striatum of Rats with Altered Function of VMAT2
Gołembiowska, K., & Dziubina, A. (2012) · Neurotoxicity Research · doi:10.1007/s12640-012-9316-9 · Cited by 37
Environmental-Genetic Interactions in the Pathogenesis of Parkinson's Disease
Tsuboi, Y. (2012) · Experimental Neurobiology · doi:10.5607/en.2012.21.3.123 · Cited by 39
Adenosine and dopamine receptor interactions in striatum and caffeine-induced behavioral activation.
Xie, X., Ramkumar, V., & Toth, L. A. (2007) · PubMed · Cited by 37
Effectiveness of topical caffeine in cataract prevention: studies with galactose cataract.
Varma, S. D., Ковтун, С. И., & Hegde, K. R. (2010) · PubMed · Cited by 37
Effects of Adenosine Receptor Antagonists on the In Vivo LPS-Induced Inflammation Model of Parkinson’s Disease
Gołembiowska, K., Wardas, J., Noworyta, K., Kamińska, K., & Górska, A. M. (2013) · Neurotoxicity Research · doi:10.1007/s12640-012-9372-1 · Cited by 38
The effects of systemic, intrastriatal, and intrapallidal injections of caffeine and systemic injections of A2A and A1 antagonists on forepaw stepping in the unilateral 6-OHDA-lesioned rat
Kelsey, J. E., Langelier, N. A., Oriel, B. S., & Reedy, C. (2008) · Psychopharmacology · doi:10.1007/s00213-008-1319-0 · Cited by 37
Inverse associations of outdoor activity and vitamin D intake with the risk of Parkinson’s disease
Zhu, D., Liu, G., Lv, Z., Wen, S., Bi, S., & Wang, W. (2014) · Journal of Zhejiang University SCIENCE B · doi:10.1631/jzus.b1400005 · Cited by 36
What Knock-Out Animals Tell Us About the Effects of Caffeine
Chen, J., Yu, L., Shen, H., He, J., Wang, X., & Zheng, R. (2010) · Journal of Alzheimer s Disease · doi:10.3233/jad-2010-1403 · Cited by 35
Association between the Prevalence of Metabolic Syndrome and the Level of Coffee Consumption among Korean Women
Kim, K., Kim, K., & Park, S. M. (2016) · PLoS ONE · doi:10.1371/journal.pone.0167007 · Cited by 35
Tea and coffee consumption in relation to DNA methylation in four European cohorts
Ek, W. E., Tobi, E. W., Ahsan, M., Lampa, E., Ponzi, E., Kyrtopoulos, S. Α., Georgiadis, P., Lumey, L. H., Heijmans, B. T., Botsivali, M., et al. (2017) · Human Molecular Genetics · doi:10.1093/hmg/ddx194 · Cited by 35
Epidemiology of atypical parkinsonian syndromes
Lo, R. Y. (2021) · Tzu Chi Medical Journal · doi:10.4103/tcmj.tcmj_218_20 · Cited by 41
Calcium Deregulation in Neurodegeneration and Neuroinflammation in Parkinson’s Disease: Role of Calcium-Storing Organelles and Sodium–Calcium Exchanger
Bastioli, G., Piccirillo, S., Graciotti, L., Carone, M., Sprega, G., Taoussi, O., Preziuso, A., & Castaldo, P. (2024) · Cells · doi:10.3390/cells13151301 · Cited by 38
Coffee, smoking and aspirin are associated with age at onset in idiopathic Parkinson’s disease
Gabbert, C., König, I. R., Lüth, T., Kolms, B., Kasten, M., Vollstedt, E., Balck, A., Study, F. I., Grünewald, A., Klein, C., et al. (2022) · Journal of Neurology · doi:10.1007/s00415-022-11041-x · Cited by 32
The Epigenetic Effects of Coffee
Ding, Q., Xu, Y., & Lau, A. T. Y. (2023) · Molecules · doi:10.3390/molecules28041770 · Cited by 33
Effect of acute administration of hydroalcohol extract of Ilex paraguariensis St Hilaire (Aquifoliaceae) in animal models of Parkinson's disease
Milioli, E. M., Cologni, P., Santos, C. C., Marcos, T., Yunes, V. M., Fernandes, M. S., Schoenfelder, T., & Costa-Campos, L. (2007) · Phytotherapy Research · doi:10.1002/ptr.2166 · Cited by 33
Caffeine and Activation Theory
(2006) · CRC Press eBooks · doi:10.1201/9781420006568 · Cited by 33
Association of serum caffeine concentrations with blood lipids in caffeine-drug users and nonusers – Results of German National Health Surveys from 1984 to 1999
Du, Y., Melchert, H.-U., Knopf, H. C., Braemer-Hauth, M., Gerding, B., & Pabel, E. (2005) · European Journal of Epidemiology · doi:10.1007/s10654-004-7536-x · Cited by 33
Effect of coffee (caffeine) against human cataract blindness
Varma, S. D. (2016) · Clinical ophthalmology · doi:10.2147/opth.s96394 · Cited by 32
Association of Coffee Consumption with MRI Markers and Cognitive Function: A Population-Based Study
Araújo, L., Mirza, S., Bos, D., Niessen, W., Barreto, S., van der Lugt, A., Vernooij, M., Hofman, A., Tiemeier, H., & Ikram, M. (2016) · Journal of Alzheimer's Disease · doi:10.3233/jad-160116 · Cited by 31
Association of brain heptachlor epoxide and other organochlorine compounds with lewy pathology
Ross, G. W., Abbott, R. D., Petrovitch, H., Duda, J. E., Tanner, C. M., Zarow, C., Uyehara‐Lock, J. H., Masaki, K., Launer, L. J., Studabaker, W. B., et al. (2018) · Movement Disorders · doi:10.1002/mds.27594 · Cited by 32
Self-citation
Knowing Your Beans in Parkinson’s Disease: A Critical Assessment of Current Knowledge about Different Beans and Their Compounds in the Treatment of Parkinson’s Disease and in Animal Models
Rijntjes, M. (2019) · Parkinson s Disease · doi:10.1155/2019/1349509 · Cited by 32
Drug repurposing strategies of relevance for Parkinson’s disease
Fletcher, E. J. R., Kaminski, T. W., Williams, G. H., & Duty, S. (2021) · Pharmacology Research & Perspectives · doi:10.1002/prp2.841 · Cited by 31
The role of environmental agents in Parkinson's disease
Monte, D. A. D. (2001) · Clinical Neuroscience Research · doi:10.1016/s1566-2772(01)00020-2 · Cited by 32
Novel adenosine A2A receptor ligands: A synthetic, functional and computational investigation of selected literature adenosine A2A receptor antagonists for extending into extracellular space
Jörg, M., Shonberg, J., Mak, F. S., Miller, N. D., Yuriev, E., Scammells, P. J., & Capuano, B. (2013) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2013.03.070 · Cited by 31
The Pathophysiology and Treatment of Essential Tremor: The Role of Adenosine and Dopamine Receptors in Animal Models
Kosmowska, B., & Wardas, J. (2021) · Biomolecules · doi:10.3390/biom11121813 · Cited by 31
Neuroproteomics as a promising tool in Parkinson’s disease research
Pienaar, I. S., Daniels, W. M. U., & Götz, J. (2008) · Journal of Neural Transmission · doi:10.1007/s00702-008-0070-3 · Cited by 32
Migraine and the Extrapyramidal System
Barbanti, P., & Fabbrini, G. (2002) · Cephalalgia · doi:10.1046/j.1468-2982.2002.00313.x · Cited by 31
Parkinson's disease
Siderowf, A. D. (2001) · Neurologic Clinics · doi:10.1016/s0733-8619(05)70035-9 · Cited by 31
Impact of genetic predisposition to late-onset neurodegenerative diseases on early life outcomes and brain structure
Ogonowski, N. S., García‐Marín, L. M., Fernando, A. S., Flores‐Ocampo, V., & Rentería, M. E. (2024) · Translational Psychiatry · doi:10.1038/s41398-024-02898-9 · Cited by 31
A Narrative Review of Lifestyle Factors Associated with Parkinson’s Disease Risk and Progression
Nag, N., & Jelinek, G. A. (2019) · Neurodegenerative Diseases · doi:10.1159/000502292 · Cited by 32
Functional and Neuroprotective Role of Striatal Adenosine A 2A Receptor Heterotetramers
Ferré, S., & Ciruela, F. (2019) · Journal of Caffeine and Adenosine Research · doi:10.1089/caff.2019.0008 · Cited by 35
Epidemiology of Parkinson’s Disease in Rural Gujarat, India
Je, G., Arora, S., Raithatha, S. J., Barrette, R., Valizadeh, N., Shah, U. M., Desai, D., Deb, A., & Desai, S. (2021) · Neuroepidemiology · doi:10.1159/000515030 · Cited by 30
A CD14 monocyte receptor polymorphism and genetic susceptibility to Parkinson's disease for females
Lin, J.-J., Chen, C., Yueh, K.-C., Chang, C. Y., & Lin, S. Z. (2005) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2005.07.010 · Cited by 30
Differential effect of environmental risk factors on postural instability gait difficulties and tremor dominant Parkinson's disease
SKEIE, G. O., Müller, B. P., Haugarvoll, K., Larsen, J. O., & Tysnes, O. (2010) · Movement Disorders · doi:10.1002/mds.23178 · Cited by 30
Biophysical Characterization of α-Synuclein and Rotenone Interaction
Silva, B., Einarsdóttir, Ó., Fink, A. L., & Uversky, V. N. (2013) · Biomolecules · doi:10.3390/biom3030703 · Cited by 30
Effect of caffeine on the intraocular pressure in patients with primary open angle glaucoma
Varma, S. D., & Chandramouli, M. (2011) · Clinical ophthalmology · doi:10.2147/opth.s25291 · Cited by 30
Therapeutic Opportunities for Caffeine and A2A Receptor Antagonists in Retinal Diseases
Boia, R., Ambrósio, A. F., & Santiago, A. R. (2016) · Ophthalmic Research · doi:10.1159/000443893 · Cited by 30
Protective effects of coffee against oxidative stress induced by the tobacco carcinogen benzo[α]pyrene
Kalthoff, S., Landerer, S., Reich, J., & Strassburg, C. P. (2017) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2017.03.006 · Cited by 31
Selected health and lifestyle factors, cytosine‐adenine‐guanine status, and phenoconversion in Huntington's disease
Tanner, C. M., Marder, K. S., Eberly, S. W., Biglan, K., Oakes, D., Shoulson, I., & on behalf of the Huntington Study Group Prospective Huntington At‐Risk Observational Study Investigators (2018) · Movement Disorders · doi:10.1002/mds.27239 · Cited by 29
Metabolic Enhancement of the Soldier Brain
Friedl, K. E., & Grate, S. J. (2019) · Oxford University Press eBooks · doi:10.1093/oso/9780190455132.003.0002 · Cited by 29
Genes Implicated in Familial Parkinson’s Disease Provide a Dual Picture of Nigral Dopaminergic Neurodegeneration with Mitochondria Taking Center Stage
Franco, R., Rivas‐Santisteban, R., Navarro, G., Pinna, A., & Reyes‐Resina, I. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22094643 · Cited by 31
Environmental Determinants of Parkinson's Disease
Wright, J. M., & Keller‐Byrne, J. E. (2005) · Archives of Environmental & Occupational Health · doi:10.3200/aeoh.60.1.32-38 · Cited by 29
Caffeine and Progression of Parkinson Disease
Simon, D. K., Wu, C., Tilley, B. C., Wills, A.-M. A., Aminoff, M. J., Bainbridge, J. L., Hauser, R. A., Schneider, J. S., Sharma, S., Singer, C., et al. (2015) · Clinical Neuropharmacology · doi:10.1097/wnf.0000000000000102 · Cited by 31
Semiquantitative study of current coffee, caffeine, and ethanol intake in essential tremor cases and controls
Louis, E. D., Jurewicz, E. C., Applegate, L. M., Luchsinger, J. A., Factor-Litvak, P. R., & Parides, M. K. (2004) · Movement Disorders · doi:10.1002/mds.20035 · Cited by 29
Chronic A2A antagonist treatment alleviates parkinsonian locomotor deficiency in MitoPark mice
Marcellino, D. J., Lindqvist, E., Schneider, M., Müller, C. E., Fuxé, K., Olson, L., & Galter, D. (2010) · Neurobiology of Disease · doi:10.1016/j.nbd.2010.07.008 · Cited by 28
The adenosine A2A antagonistic properties of selected C8-substituted xanthines
der Walt, M. M. V., Terre’Blanche, G., Petzer, A., Lourens, A. C. U., & Petzer, J. P. (2013) · Bioorganic Chemistry · doi:10.1016/j.bioorg.2013.06.006 · Cited by 28
Prevention of respiratory infections in the elderly
Yamaya, M., Ohrui, T., Kubo, H., Ebihara, S., Arai, H., & Sasaki, H. (2002) · Geriatrics and gerontology international/Geriatrics & gerontology international · doi:10.1046/j.1444-1586.2002.00034.x · Cited by 27
Parkinson's disease: the nutrition perspective
Breasail, M. Ó., Smith, M. D., Tenison, E., Henderson, E. J., & Lithander, F. E. (2021) · Proceedings of The Nutrition Society · doi:10.1017/s0029665121003645 · Cited by 32
To sip or not to sip: the potential health risks and benefits of coffee drinking
Taylor, S. R., & Demmig‐Adams, B. (2007) · Nutrition & Food Science · doi:10.1108/00346650710838063 · Cited by 27
8‐Benzyltetrahydropyrazino[2,1‐f]purinediones: Water‐Soluble Tricyclic Xanthine Derivatives as Multitarget Drugs for Neurodegenerative Diseases
Brunschweiger, A., Koch, P., Schlenk, M., Pineda, F., Küppers, P., Hinz, S., Köse, M., Ullrich, S., Hockemeyer, J., Wiese, M., et al. (2014) · ChemMedChem · doi:10.1002/cmdc.201402082 · Cited by 27
Potential Role of Caffeine in the Treatment of Parkinson’s Disease
Roshan, M. H. K., Tambo, A., & Pace, N. P. (2016) · The Open Neurology Journal · doi:10.2174/1874205x01610010042 · Cited by 33
Adenosine receptor signaling in vitro and in vivo
Fredholm, B. B., Arslan, G., Halldner, L., Kull, B., Schulte, G., Ådén, U., & Svenningsson, P. (2001) · Drug Development Research · doi:10.1002/ddr.1124 · Cited by 27
Topology of the Interactions Pattern in Pharmaceutically Relevant Polymorphs of Methylxanthines (Caffeine, Theobromine, and Theophiline): Combined Experimental (1H–14N Nuclear Quadrupole Double Resonance) and Computational (DFT and Hirshfeld-Based) Study
Latosińska, J. N., Latosińska, M., Olejniczak, G. A., Seliger, J., & Žagar, V. (2014) · Journal of Chemical Information and Modeling · doi:10.1021/ci5004224 · Cited by 26
Neurochemical and Neurotoxic Effects of MDMA (Ecstasy) and Caffeine After Chronic Combined Administration in Mice
Górska, A. M., Kamińska, K., Wawrzczak‐Bargieła, A., Costa, G., Morelli, M., Przewłocki, R., Kreiner, G., & Gołembiowska, K. (2017) · Neurotoxicity Research · doi:10.1007/s12640-017-9831-9 · Cited by 25
Sarcopenic obesity is associated with coffee intake in elderly Koreans
Lee, D., & Shin, S. (2023) · Frontiers in Public Health · doi:10.3389/fpubh.2023.990029 · Cited by 25
Targeting the Chameleon: a Focused Look at α-Synuclein and Its Roles in Neurodegeneration
Silva, B. A., Breydo, L., & Uversky, V. N. (2012) · Molecular Neurobiology · doi:10.1007/s12035-012-8334-1 · Cited by 25
Protective effect of caffeine against high sugar-induced transcription of microRNAs and consequent gene silencing: a study using lenses of galactosemic mice.
Varma, S. D., & Ковтун, С. И. (2013) · Europe PMC (PubMed Central) · Cited by 25
ALGUNAS VERDADES SOBRE EL CAFÉ
Gotteland, M., & de Pablo, S., V (2007) · Revista chilena de nutrición · doi:10.4067/s0717-75182007000200002 · Cited by 25
Neuroprotection in Parkinson Disease
Simpkins, N., & Jankovic, J. J. (2003) · Archives of Internal Medicine · doi:10.1001/archinte.163.14.1650 · Cited by 25
The coffee ingredients caffeic acid and caffeic acid phenylethyl ester protect against irinotecan‐induced leukopenia and oxidative stress response
Kalthoff, S., Paulusch, S., Rupp, A. B. A., Holdenrieder, S., Hartmann, G., & Strassburg, C. P. (2020) · British Journal of Pharmacology · doi:10.1111/bph.15162 · Cited by 24
Adenosine Receptor Ligands and PET Imaging of the CNS
Bauer, A., & Ishiwata, K. (2009) · Handbook of experimental pharmacology · doi:10.1007/978-3-540-89615-9_19 · Cited by 25
Human Monocyte Recognition of Adenosine-Based Cyclic Dinucleotides Unveils the A2a GαsProtein-Coupled Receptor Tonic Inhibition of Mitochondrially Induced Cell Death
Tosolini, M., Pont, F., Bétous, D., Ravet, E., Ligat, L., Lopez, F., Poupot, M., Poirot, M., Pérouzel, É., Tiraby, G., et al. (2014) · Molecular and Cellular Biology · doi:10.1128/mcb.01204-14 · Cited by 24
Formulations of hormone therapy and risk of Parkinson's disease
Lundin, J. I., Ton, T. G. N., LaCroix, A. Z., Longstreth, W. T., Franklin, G. M., Swanson, P. D., Smith‐Weller, T., Racette, B. A., & Checkoway, H. (2014) · Movement Disorders · doi:10.1002/mds.26037 · Cited by 26
Novel therapy in Parkinson's disease: adenosine A2Areceptor antagonists
Szabó, N., Kincses, Z. T., & Vécsei, L. (2011) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1517/17425255.2011.557066 · Cited by 26
Interaction between caffeine and polymorphisms of glutamate ionotropic receptor NMDA type subunit 2A (GRIN2A) and cytochrome P450 1A2 (CYP1A2) on Parkinson's disease risk
Kim, I. Y., O’Reilly, É. J., Hughes, K. C., Gao, X., Schwarzschild, M. A., McCullough, M. L., Hannan, M. T., Betensky, R. A., & Ascherio, A. (2018) · Movement Disorders · doi:10.1002/mds.27279 · Cited by 25
Caffeine Stimulates Cytochrome Oxidase Expression and Activity in the Striatum in a Sexually Dimorphic Manner
Jones, F. S., Jing, J., Stonehouse, A. H., Stevens, A., & Edelman, G. M. (2008) · Molecular Pharmacology · doi:10.1124/mol.108.046888 · Cited by 24
Patients’ perceptions on the impact of coffee consumption in inflammatory bowel disease: friend or foe? – a patient survey
Barthel, C., Wiegand, S., Scharl, S., Scharl, M. M., Frei, P., Vavricka, S. R., Fried, M., Sulz, M. C., Wiegand, N., Rogler, G., et al. (2015) · Nutrition Journal · doi:10.1186/s12937-015-0070-8 · Cited by 23
Caffeine's Implications for Women's Health and Survey of Obstetrician-Gynecologists' Caffeine Knowledge and Assessment Practices
Anderson, B. L., Juliano, L. M., & Schulkin, J. A. (2009) · Journal of Women s Health · doi:10.1089/jwh.2008.1186 · Cited by 23
Effect of Adenosine A2A Receptor Antagonists and l-DOPA on Hydroxyl Radical, Glutamate and Dopamine in the Striatum of 6-OHDA-Treated Rats
Gołembiowska, K., & Dziubina, A. (2011) · Neurotoxicity Research · doi:10.1007/s12640-011-9263-x · Cited by 23
Caffeine, a natural methylxanthine nutraceutical, exerts dopaminergic neuroprotection
Karuppagounder, S. S., Uthaythas, S., Govindarajulu, M., Ramesh, S., Parameshwaran, K., & Dhanasekaran, M. (2021) · Neurochemistry International · doi:10.1016/j.neuint.2021.105066 · Cited by 26
Effect of Adenosine A2A Receptor Antagonists on l-DOPA-Induced Hydroxyl Radical Formation in Rat Striatum
Gołembiowska, K., Dziubina, A., Kowalska, M., & Kamińska, K. (2009) · Neurotoxicity Research · doi:10.1007/s12640-009-9016-2 · Cited by 23
Association of Coffee Consumption with Sarcopenia in Korean Elderly Men: Analysis Using the Korea National Health and Nutrition Examination Survey, 2008–2011
Chung, H., Moon, J. H., Kim, J. I., Kong, M. H., Huh, J. S., & Kim, H. J. (2017) · Korean Journal of Family Medicine · doi:10.4082/kjfm.2017.38.3.141 · Cited by 22
A review of diagnostic imaging approaches to assessing Parkinson's disease
Samson, E., & Noseworthy, M. D. (2022) · Brain Disorders · doi:10.1016/j.dscb.2022.100037 · Cited by 23
Shared Metabolic Profile of Caffeine in Parkinsonian Disorders
Takeshige‐Amano, H., Saiki, S., Fujimaki, M., Ueno, S., Li, Y., Hatano, T., Ishikawa, K., Oji, Y., Mori, A., Okuzumi, A., et al. (2020) · Movement Disorders · doi:10.1002/mds.28068 · Cited by 20
Mechanistic Study of Coffee Effects on Gut Microbiota and Motility in Rats
Hegde, S., Shi, D. W., Johnson, J. C., Geesala, R., Zhang, K., Lin, Y.-M., & Shi, X.-Z. P. (2022) · Nutrients · doi:10.3390/nu14224877 · Cited by 22

Authors: Ross, G. W.
Affiliations: United States Department of Veterans Affairs (US)
Corresponding author: Ross, G. Webster
Venue: JAMA
Publisher: American Medical Association (AMA)
Published: 2000-05-24
Volume: 283
Issue: 20
Pages: 2674
ISSN: 0002-9955 (ISSN-L)
0098-7484
DOI: 10.1001/jama.283.20.2674
OpenAlex: W2128822428
Cited by: 778
References: 35
Citations by year: 2026: 8 · 2025: 24 · 2024: 28 · 2023: 34 · 2022: 22 · 2021: 39 · 2020: 26 · 2019: 35 · 2018: 26 · 2017: 36 · 2016: 24 · 2015: 29 · 2014: 39 · 2013: 37 · 2012: 36
FWCI: 17.73
Type: journal article
Language: en
Open access: closed
Locations: JAMA (publishedVersion)
PubMed (publishedVersion)
Funders: National Institutes of Health (n01hc005102-027, DAMD17-98-1-8621)
National Institute on Aging (N01‐AG‐4‐2149)
National Heart, Lung, and Blood Institute (N01 HC 05102, NO1-HC-05102)
Topics: Health Sciences › Medicine › Clinical Neurology › Parkinson's Disease Mechanisms and Treatments
Health Sciences › Medicine › Pharmacology (medical) › Coffee research and impacts
Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
Keywords: Parkinson's disease, coffee consumption, dietary caffeine, caffeine consumption, smoking, nicotinic acid, Honolulu Heart Program, Japanese-American men, disease incidence
MeSH terms: Aged, Caffeine, Coffee, Diet Surveys, Humans, Longitudinal Studies, Male, Middle Aged, Parkinson Disease, Regression Analysis, Risk Factors, Incidence

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Association of Coffee and Caffeine Intake With the Risk of Parkinson Disease

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks